These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7937648)

  • 1. [Risk of occupational cancers. Effect of deoxyribonucleic acid adducts].
    Deschamps F; Pfohl-Leszkowicz A; Trenque T
    Presse Med; 1994 Jun; 23(21):991-4. PubMed ID: 7937648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin adducts for in vivo dose monitoring and cancer risk estimation.
    Törnqvist M; Landin HH
    J Occup Environ Med; 1995 Sep; 37(9):1077-85. PubMed ID: 8528715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung.
    Wiencke JK; Kelsey KT; Varkonyi A; Semey K; Wain JC; Mark E; Christiani DC
    Cancer Res; 1995 Nov; 55(21):4910-4. PubMed ID: 7585529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biologically effective dose biomarkers].
    Miraglia N; Assennato G; Clonfero E; Fustinoni S; Sannolo N
    G Ital Med Lav Ergon; 2004; 26(4):298-301. PubMed ID: 15584436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of cancer risk caused by environmental chemicals based on in vivo dose measurement.
    Törnqvist M; Ehrenberg L
    J Environ Pathol Toxicol Oncol; 2001; 20(4):263-71. PubMed ID: 11797835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxic damage in mine workers exposed to diesel exhaust, and the effects of glutathione transferase genotypes.
    Knudsen LE; Gaskell M; Martin EA; Poole J; Scheepers PT; Jensen A; Autrup H; Farmer PB
    Mutat Res; 2005 Jun; 583(2):120-32. PubMed ID: 15876548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic DNA adducts in white blood cells of foundry workers.
    Hemminki K; Perera FP; Phillips DH; Randerath K; Reddy MV; Santella RM
    IARC Sci Publ; 1988; (89):190-5. PubMed ID: 3143668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring occupational exposure to carcinogens.
    Schoket B
    IARC Sci Publ; 1993; (124):341-7. PubMed ID: 8225504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational cancer in Israel: an overview.
    Shaham J; Ribak J
    Isr J Med Sci; 1992; 28(8-9):520-5. PubMed ID: 1428805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adducts as markers of exposure and risk.
    Phillips DH
    Mutat Res; 2005 Sep; 577(1-2):284-92. PubMed ID: 15922369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosimetry of DNA and protein adducts in occupational health].
    Pavanello S; Clonfero E
    Med Lav; 1994; 85(5):363-9. PubMed ID: 7885291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomonitoring of workers exposed to carcinogens: immunoassays to benzo(a)pyrene-DNA adducts as a prototype.
    Perera F; Santella R; Poirier M
    J Occup Med; 1986 Oct; 28(10):1117-23. PubMed ID: 3095513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA adducts among asphalt paving workers.
    McClean MD; Wiencke JK; Kelsey KT; Varkonyi A; Ngo L; Eisen EA; Herrick RF
    Ann Occup Hyg; 2007 Jan; 51(1):27-34. PubMed ID: 17046959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.